| scholarly article | Q13442814 |
| review article | Q7318358 |
| P6179 | Dimensions Publication ID | 1017956650 |
| P356 | DOI | 10.1038/SJ.EYE.6702603 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/sj.eye.6702603 |
| P698 | PubMed publication ID | 16980921 |
| P5875 | ResearchGate publication ID | 6813198 |
| P2093 | author name string | Edwards R | |
| Kelly SP | |||
| Thornton J | |||
| Harrison RA | |||
| P2860 | cites work | The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease | Q72812221 |
| High-dose intravenous steroid pulse therapy in thyroid-associated ophthalmopathy | Q73166789 | ||
| Cigarette smoking and treatment outcomes in Graves ophthalmopathy | Q77458223 | ||
| Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking | Q81490171 | ||
| Smoking and autoimmune thyroid disease: the plot thickens | Q83854188 | ||
| Recent developments in thyroid eye disease | Q24564205 | ||
| The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions | Q27860564 | ||
| Graves' ophthalmopathy: a preventable disease? | Q28210494 | ||
| What is a cause and how do we know one? A grammar for pragmatic epidemiology. | Q30385941 | ||
| Smoking and thyroid disorders--a meta-analysis | Q33845621 | ||
| Long-term results of irradiation for patients with progressive Graves' ophthalmopathy | Q34430156 | ||
| Smoking and age-related macular degeneration: a review of association. | Q34449581 | ||
| Impact of smoking on the response to treatment of thyroid associated ophthalmopathy | Q35591093 | ||
| Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. | Q35606170 | ||
| Relationship between cigarette smoking and Graves' ophthalmopathy | Q35785152 | ||
| Smoking and cataract: review of causal association. | Q36394342 | ||
| More on smoking habits and Graves' ophthalmopathy | Q44906164 | ||
| Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease | Q46580927 | ||
| Perceptions of blindness related to smoking: a hospital-based cross-sectional study | Q47605644 | ||
| The treatment of Graves' ophthalmopathy in an incidence cohort. | Q51034070 | ||
| Smoking and Risk of Graves' Disease | Q54186495 | ||
| The association between cigarette smoking and ocular diseases | Q64050071 | ||
| Association between Graves' ophthalmopathy and smoking | Q68088136 | ||
| Graves' disease, endocrine ophthalmopathy and smoking | Q70605949 | ||
| Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption | Q71871480 | ||
| Graves' ophthalmopathy and tobacco smoking | Q72232071 | ||
| P433 | issue | 9 | |
| P921 | main subject | systematic review | Q1504425 |
| eye disease | Q3041498 | ||
| cigarette smoking | Q67433631 | ||
| P304 | page(s) | 1135-1145 | |
| P577 | publication date | 2006-09-15 | |
| P1433 | published in | Eye | Q10278937 |
| P1476 | title | Cigarette smoking and thyroid eye disease: a systematic review | |
| P478 | volume | 21 |
| Q35582576 | Adverse effects of smoking on patients with ocular inflammation |
| Q94340078 | Answer: Can you identify this condition? |
| Q33842343 | Association of BTG2, CYR61, ZFP36, and SCD gene polymorphisms with Graves' disease and ophthalmopathy |
| Q50179455 | Cigarette smoking and glaucoma in the United States population. |
| Q37196715 | Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population. |
| Q33695558 | Cigarette smoking as a risk factor for uveitis |
| Q91858998 | Current Understanding of the Progression and Management of Thyroid Associated Orbitopathy: A Systematic Review |
| Q48503479 | Epidemiology and Clinical Features of Thyroid-associated Orbitopathy in Accra. |
| Q36318253 | Genetic associations of FCRL3 polymorphisms with the susceptibility of Graves ophthalmopathy in a Chinese population |
| Q47399634 | Geriatric patients are predisposed to strabismus following thyroid-related orbital decompression surgery: A multivariate analysis |
| Q33794950 | Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts-a possible explanation of the link between smoking and Graves' ophthalmopathy. |
| Q57819621 | Imaging biomarkers in thyroid eye disease and their clinical associations |
| Q38130235 | Medical management of thyroid eye disease |
| Q35547833 | Meta-analysis of association between the +49A/G polymorphism of cytotoxic T-lymphocyte antigen-4 and thyroid associated ophthalmopathy. |
| Q46320003 | Oxidative stress in patients with Graves' ophthalmopathy: relationship between oxidative DNA damage and clinical evolution. |
| Q38633022 | Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. |
| Q40678838 | Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role? |
| Q37715255 | Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India |
| Q42656691 | Prognostic indicators for the development of strabismus among patients with graves' ophthalmopathy |
| Q24186122 | Radioiodine therapy versus antithyroid medications for Graves' disease |
| Q34200995 | Risk factors associated with the severity of thyroid-associated orbitopathy in Korean patients. |
| Q89948348 | Shining a light on thyroid eye disease |
| Q38098569 | Smoking and thyroid |
| Q95322318 | The aryl hydrocarbon receptor pathway controls matrix metalloproteinase-1 and collagen levels in human orbital fibroblasts |
| Q35607571 | The role of oxidative stress on the pathogenesis of graves' disease |
| Q34220709 | Thyroid associated ophthalmopathy - a review |
| Q86525873 | Thyroid eye disease |
| Q38971992 | Thyroid eye disease: a review |
| Q37987063 | Thyroid eye disease: towards an evidence base for treatment in the 21st century |
| Q53743982 | Thyroid-associated Ophthalmopathy. |
| Q93333216 | Tocilizumab for thyroid eye disease |
| Q94355143 | Tocilizumab for thyroid eye disease |
| Q39205538 | Treatment options for thyroid eye disease |
| Q83079598 | [Effects of smoking on the thyroid gland, digestive system, kidney and bone] |
Search more.